An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder-Reference-Cited by-同舟云学术

An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder

Published:2009-08 Issue:4 Volume:19 Page:431-439
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Findling Robert L.¹,Kauffman Ralph²,Sallee Floyd R.³,Salazar Daniel E.⁴,Sahasrabudhe Vaishali⁴,Kollia Georgia⁴,Kornhauser David M.⁴,Vachharajani Nimish N.⁴,Assuncao-Talbott Sheila⁵,Mallikaarjun Suresh⁶,Iwamoto Taro⁷,McQuade Robert D.⁸,Boulton David W.⁴,Blumer Jeffrey⁹

Affiliation:

1. University Hospitals Case Medical Center, Cleveland, Ohio.

2. University of Missouri-Kansas City, Children's Mercy Hospital, Kansas City, Missouri.

3. Children's Hospital Medical Center, Cincinnati, Ohio.

4. Bristol-Myers Squibb, Princeton, New Jersery.

5. Bristol-Myers Squibb, Plainsboro, New Jersey.

6. Otsuka Maryland Research Institute, Rockville, Maryland.

7. Otsuka Pharmaceutical Co. Ltd, Tokyo, Japan.

8. Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, New Jersey.

9. Department of Pediatrics and Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2008.0111

Reference34 articles.

1. Abilify: Bristol-Myers Squibb/Otsuka America Pharmaceutical Inc., Aripiprazole (Abilify) Prescribing Information. Bristol-Myers Squibb & Otsuka America Pharmaceutical Inc. Princeton (New Jersey), 2007.

2. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol

3. A Simple Objective Technique for Measuring Flexibility in Thinking

4. The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacokinetics of antipsychotics in pediatric populations: a scoping review focusing on dosing regimen;Expert Opinion on Drug Metabolism & Toxicology;2023-08-03

2. Towards precision dosing of aripiprazole in children and adolescents with autism spectrum disorder: Linking blood levels to weight gain and effectiveness;British Journal of Clinical Pharmacology;2023-06-13

3. The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone;Human Psychopharmacology: Clinical and Experimental;2023-02-22

4. Relationship Between Plasma Aripiprazole and Dehydroaripiprazole Concentrations and Prolactin Levels in Chinese Children and Adolescents;Journal of Child and Adolescent Psychopharmacology;2023-02-01

5. Entwicklungspsychopharmakologie;Neuro-/Psychopharmaka im Kindes- und Jugendalter;2023